Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poh, T. W.
Right arrow Articles by Pervaiz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poh, T. W.
Right arrow Articles by Pervaiz, S.
[Cancer Research 65, 6264-6274, July 15, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

LY294002 and LY303511 Sensitize Tumor Cells to Drug-Induced Apoptosis via Intracellular Hydrogen Peroxide Production Independent of the Phosphoinositide 3-Kinase-Akt Pathway

Tze Wei Poh1 and Shazib Pervaiz1,2,3

1 Department of Physiology, 2 Oncology Research Institute, National University Medical Institute, Faculty of Medicine, and 3 Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore, Singapore

Requests for reprints: Shazib Pervaiz, Department of Physiology, MD902-05, Faculty of Medicine, National University of Singapore, Singapore, Singapore 117597. Fax: 65-67788161; E-mail: phssp{at}nus.edu.sg.

The phosphoinositide 3-kinase (PI3K)-Akt pathway is constitutively active in many tumors, and inhibitors of this prosurvival network, such as LY294002, have been shown to sensitize tumor cells to death stimuli. Here, we report a novel, PI3K-independent mechanism of LY-mediated sensitization of LNCaP prostate carcinoma cells to drug-induced apoptosis. Preincubation of tumor cells to LY294002 or its inactive analogue LY303511 resulted in a significant increase in intracellular hydrogen peroxide (H2O2) production and enhanced sensitivity to nonapoptotic concentrations of the chemotherapeutic agent vincristine. The critical role of intracellular H2O2 in LY-induced death sensitization is corroborated by transient transfection of cells with a vector containing human catalase gene. Indeed, overexpression of catalase significantly blocked the amplifying effect of LY pretreatment on caspase-2 and caspase-3 activation and cell death triggered by vincristine. Furthermore, the inability of wortmannin, another inhibitor of PI3K, to induce an increase in H2O2 production at doses that effectively blocked Akt phosphorylation provides strong evidence to unlink inhibition of PI3K from intracellular H2O2 production. These data strongly support death-sensitizing effect of LY compounds independent of the PI3K pathway and underscore the critical role of H2O2 in creating a permissive intracellular milieu for efficient drug-induced execution of tumor cells.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
C. Martin-Fernandez, J. Bales, C. Hodgkinson, A. Welman, M. J. Welham, C. Dive, and C. J. Morrow
Blocking Phosphoinositide 3-Kinase Activity in Colorectal Cancer Cells Reduces Proliferation but Does Not Increase Apoptosis Alone or in Combination with Cytotoxic Drugs
Mol. Cancer Res., June 1, 2009; 7(6): 955 - 965.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Shenoy, Y. Wu, and S. Pervaiz
LY303511 Enhances TRAIL Sensitivity of SHEP-1 Neuroblastoma Cells via Hydrogen Peroxide-Mediated Mitogen-Activated Protein Kinase Activation and Up-regulation of Death Receptors
Cancer Res., March 1, 2009; 69(5): 1941 - 1950.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Billottet, L. Banerjee, B. Vanhaesebroeck, and A. Khwaja
Inhibition of Class I Phosphoinositide 3-Kinase Activity Impairs Proliferation and Triggers Apoptosis in Acute Promyelocytic Leukemia without Affecting Atra-Induced Differentiation
Cancer Res., February 1, 2009; 69(3): 1027 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Fushimi, P. Ray, A. Kar, L. Wang, L. C. Sutherland, and J. Y. Wu
Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5
PNAS, October 14, 2008; 105(41): 15708 - 15713.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Chu, H. Xu, T. J. Ferro, and P. X. Rivera
Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1127 - L1134.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. I. Raynaud, S. Eccles, P. A. Clarke, A. Hayes, B. Nutley, S. Alix, A. Henley, F. Di-Stefano, Z. Ahmad, S. Guillard, et al.
Pharmacologic Characterization of a Potent Inhibitor of Class I Phosphatidylinositide 3-Kinases
Cancer Res., June 15, 2007; 67(12): 5840 - 5850.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Mandal and T. Hamilton
Signaling in Lipopolysaccharide-Induced Stabilization of Formyl Peptide Receptor 1 mRNA in Mouse Peritoneal Macrophages
J. Immunol., February 15, 2007; 178(4): 2542 - 2548.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
W. D. Heo, T. Inoue, W. S. Park, M. L. Kim, B. O. Park, T. J. Wandless, and T. Meyer
PI(3,4,5)P3 and PI(4,5)P2 Lipids Target Proteins with Polybasic Clusters to the Plasma Membrane
Science, December 1, 2006; 314(5804): 1458 - 1461.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. A. Ahmad, G. Wang, and K. Ahmed
Intracellular Hydrogen Peroxide Production Is an Upstream Event in Apoptosis Induced by Down-Regulation of Casein Kinase 2 in Prostate Cancer Cells
Mol. Cancer Res., May 1, 2006; 4(5): 331 - 338.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Beloueche-Babari, L. E. Jackson, N. M.S. Al-Saffar, S. A. Eccles, F. I. Raynaud, P. Workman, M. O. Leach, and S. M. Ronen
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells
Mol. Cancer Ther., January 1, 2006; 5(1): 187 - 196.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.